Letter to the Editor
Soluble suppression of tumorigenicity-2 for risk stratification in outpatients with heart failure
1Department of Cardiology, Faculty of Medicine, Alanya Alaaddin Keykubat University; Antalya-Turkey
Anatol J Cardiol 2018; 19(3): 228-228 PubMed ID: 29521320 PMCID: 5864776 DOI: 10.14744/AnatolJCardiol.2018.05914
Keywords: heart failure, soluble suppression of tumorigenicity-2, cardiovascular mortality